CN Healthy Food Tech Group Corp.

Other than as set forth below, there have been no material changes from the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K, as amended, for the year ended December 31, 2025, and Part II, Item 1A of each of our Quarterly Report on Form 10-Q, for the quarterly period ended March 31, 2026, filed with the SEC on May 13, 2026, and our Quarterly Report on Form 10-Q, for the quarterly period ended June 30, 2026, filed with the SEC on August 14, 2026..

Risks Related to the Continued Nasdaq Trading Halt

Following our listing on the Nasdaq Capital Market on October 1, 2025, Nasdaq notified us that the China Securities Regulatory Commission (the “CSRC”) had not yet completed its process of review of our U.S. listing, and Nasdaq halted trading of our common stock and warrants on that date pending receipt of additional clarification. On July 16, 2026, we received a letter from the Listing Qualifications Staff of Nasdaq (the “Staff”) stating that the Staff had determined to delist our common stock and warrants based on Nasdaq’s discretionary authority under Nasdaq Listing Rule 5101 and IM-5101-1 and our alleged violation of Nasdaq Listing Rules 5205(e) and 5250(a)(1). We timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”), which was held on August 27, 2026.

On October 7, 2026, the Panel issued a decision finding us in compliance with the Nasdaq Listing Rules and granting our request to remain listed, subject to conditions, including a one-year discretionary panel monitor. On October 20, 2026, Nasdaq announced that the trading halt in our securities will continue. Nasdaq has requested additional information from us, and trading will remain halted until we have satisfied Nasdaq’s request for information. The trading halt remained in effect as of the filing date of this Quarterly Report. We cannot assure you that we will be able to provide information satisfactory to Nasdaq, when trading in our securities will resume, if at all, or that we will satisfy the conditions imposed by the Panel during the monitoring period. If we fail to satisfy Nasdaq’s request or the Panel’s conditions, trading in our securities may remain halted indefinitely, and Nasdaq may suspend or delist our common stock and warrants. While trading remains halted, our stockholders and warrant holders are unable to sell their securities on Nasdaq, and a prolonged halt, suspension or delisting could materially and adversely affect the liquidity and market price of our securities, reduce the number of investors willing to hold or acquire our securities, damage our reputation, and impair our ability to raise capital on acceptable terms, or at all.